Open Menu
News & events

News

  • Post date

  • Tags

  • By author

Advanced search
November 17, 2020 Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabilities in the U.S.
October 12, 2020 Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh
July 1, 2020 Cambrex Increases Flexible Manufacturing Capacity at Karlskoga, Sweden Facility
June 18, 2020 Cambrex Names Thomas Loewald As Chief Executive Officer
June 2, 2020 Cambrex Announces Management Transitions
April 7, 2020 Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility
March 31, 2020 Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit
March 26, 2020 Cambrex Recognized in 2020 CMO Leadership Awards
January 6, 2020 Cambrex Announces Management Changes and Board Appointments
December 4, 2019 Cambrex Announces Completion of Acquisition by the Permira Funds
November 14, 2019 Cambrex Wins Third API Development Award at CPhI Worldwide
September 23, 2019 Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement

About us

Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle

Quality & regulatory

We deliver quality in every aspect of our work, across all of our facilities, systems and teams

Environment, health & safety

Our strong commitment to the environment and health and safety underpins all that we do at Cambrex

Cambrex careers

At Cambrex, it’s our people that set us apart. We’re committed to attracting, nurturing and retaining a passionate and talented team of experts that enjoy what they do